Landfar Bio-medicine Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Market Capitalization	3,063	2,954	2,756	3,614	3,627	5,795
Market Cap Growth	10.87%	7.19%	-23.76%	-0.34%	-37.42%	51.96%
Enterprise Value	3,201	2,941	2,522	3,679	3,774	6,136
Last Close Price	9.28	8.95	8.35	11.60	11.64	18.60
PE Ratio	70.49	102.46	-	-	-	-
PS Ratio	5.97	7.10	20.50	26.42	18.10	37.00
PB Ratio	8.30	8.26	9.77	11.86	45.23	52.53
P/TBV Ratio	14.24	14.50	11.81	14.20	696.61	726.09
P/FCF Ratio	-	-	-	119.05	24.27	77.13
P/OCF Ratio	-	-	574.87	99.63	21.80	54.11
EV/Sales Ratio	6.24	7.07	18.76	26.90	18.84	39.18
EV/EBITDA Ratio	55.81	82.96	-	-	-	-
EV/EBIT Ratio	61.80	95.28	-	-	-	-
EV/FCF Ratio	-15.01	-	-	121.19	25.26	81.67
Debt / Equity Ratio	0.95	0.96	0.09	0.67	2.95	2.83
Debt / EBITDA Ratio	6.10	9.50	-	-	-	-
Debt / FCF Ratio	-	-	-	6.72	1.58	4.16
Net Debt / Equity Ratio	0.13	-0.01	-0.65	-0.96	0.21	1.44
Net Debt / EBITDA Ratio	0.81	-0.16	14.36	8.70	-1.65	-8.62
Net Debt / FCF Ratio	-0.22	0.05	13.65	-9.61	0.11	2.11
Asset Turnover	0.63	0.52	0.20	0.21	0.33	0.26
Inventory Turnover	11.68	12.30	2.00	5.92	9.64	3.62
Quick Ratio	1.21	1.26	1.18	1.41	0.89	0.68
Current Ratio	1.38	1.36	1.32	1.45	0.91	0.98
Return on Equity (ROE)	11.07%	5.65%	-8.16%	-24.31%	-30.93%	-27.04%
Return on Assets (ROA)	4.00%	2.41%	-1.39%	-3.45%	-1.33%	-2.26%
Return on Invested Capital (ROIC)	12.94%	12.55%	-27.62%	-66.71%	-7.06%	-7.22%
Return on Capital Employed (ROCE)	11.20%	6.90%	-5.10%	-11.50%	-13.10%	-16.80%
Earnings Yield	1.38%	0.98%	-0.72%	-0.78%	-0.34%	-0.33%
FCF Yield	-6.96%	-4.09%	-0.49%	0.84%	4.12%	1.30%
Payout Ratio	7.19%	8.20%	-	-	-	-
Buyback Yield / Dilution	3.31%	3.16%	-5.67%	-0.51%	2.30%	-17.27%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.